Opinion

Video

A Case of Neovascular AMD With Treatment-Resistant Pigment Epithelium Detachment

Adiel Smith, MD, FASRS, presents the case of a patient with neovascular age-related macular degeneration (nAMD) with treatment-resistant pigment epithelium detachment, and the panel offers clinical insights on treatment decisions.

Related Videos
4 experts are featured in this series.
4 experts are featured in this series.
4 experts are featured in this series.
4 experts are featured in this series.
4 experts are featured in this series.
4 experts are featured in this series.
4 experts are featured in this series.
4 experts are featured in this series.
Bonnie An Henderson, MD, and EnVision Summit 2025 preview
Related Content
4DMT publishes preclinical data demonstrating the potential of the Therapeutic Vector Evolution (TVE) platform
December 20th 2024

4DMT publishes preclinical data demonstrating the potential of the Therapeutic Vector Evolution (TVE) platform

2025 Glaucoma 360 brings celebration, innovation, and education to San Francisco
December 13th 2024

California dreaming: 2025 Glaucoma 360 brings celebration, innovation, and education to San Francisco

Phenocell and Amarna Therapeutics awarded Eurostars grant for continued investigation of dry AMD gene therapy platform
December 13th 2024

Phenocell and Amarna Therapeutics awarded Eurostars grant for continued investigation of dry AMD gene therapy platform

EnVision Summit 2025: Advancing Ophthalmology and Optometry Together
November 19th 2024

Connect, learn, and innovate in a family-friendly atmosphere: What to expect at EnVision Summit 2025

Galimedix Therapeutics initiates phase 1 trial of oral GAL-101
December 6th 2024

Galimedix Therapeutics initiates phase 1 trial of oral GAL-101

Over 300 patients randomized in Ocular Therapeutix's SOL-1 phase 3 trial for OTX-TKI
December 4th 2024

Over 300 patients randomized in Ocular Therapeutix's SOL-1 phase 3 trial for OTX-TKI

© 2024 MJH Life Sciences

All rights reserved.